img
ADVERTISEMENT
ADVERTISEMENT

Hims and Hers Super Bowl commercial pushes left-wing CEO’s talking points

The advertisement, titled “Rich People Live Longer,” aimed at highlighting wealth inequality in the US healthcare system.

ADVERTISEMENT

The advertisement, titled “Rich People Live Longer,” aimed at highlighting wealth inequality in the US healthcare system.

Hims and Hers Health, whose CEO Andrew Dudum has donated to prominent Democratic politicians, including members of the “squad,” spent millions of dollars on a Super Bowl commercial promoting a left-wing message centered on healthcare inequality

The advertisement, titled “Rich People Live Longer,” aimed at highlighting wealth inequality in the US healthcare system. The commercial, narrated by rapper Common, showed wealthy individuals receiving superior healthcare benefits, including preventative care and easier access to specialists, before asking viewers why they should not have the same advantages. The ad suggested Hims and Hers products as the solution, positioning the company as a way for everyday Americans to access care that would typically be reserved for the wealthy.

The ad aired as scrutiny continues to surround the company’s leadership and regulatory practices. Dudum has previously donated to Democrats, including Ilhan Omar, Rashida Tlaib, Joe Biden, Kamala Harris, and Cori Bush, according to the National Pulse

Last year, Dudum drew backlash after writing that he was “eager” to hire anti-Israel student protesters, a comment that resulted in a single-day drop of nearly $210 million in the company’s stock value. In a since-deleted post referencing campus protests, Dudum wrote, “Moral courage > College degree.”

On Friday, US Department of Health and Human Services General Counsel Mike Stuart announced that Hims and Hers Health Inc. had been referred to the Department of Justice for investigation over potential violations of the Federal Food, Drug, and Cosmetic Act. The referral follows scrutiny from federal regulators over the company’s weight-loss drug that is a copycat version of Wegovy. The FDA has warned companies against selling "illegal copycat drugs.” Following the warning, Hims and Hers announced it would halt the launch of the product.

"Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry," the company said in a statement on Saturday. "As a result, we have decided to stop offering access to this treatment."

ADVERTISEMENT
ADVERTISEMENT
Sign in to comment

Comments

Powered by The Post Millennial CMS™ Comments

Join and support independent free thinkers!

We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.

Support The Post Millennial

Remind me next month

To find out what personal data we collect and how we use it, please visit our Privacy Policy

ADVERTISEMENT
ADVERTISEMENT
By signing up you agree to our Terms of Use and Privacy Policy
ADVERTISEMENT
© 2026 The Post Millennial, Privacy Policy